FRESENIUS MEDICAL CARE-ADR (FMS) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:FMS - US3580291066 - ADR
22.292 USD
+0.1 (+0.46%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 19.398B 10.10% | 19.454B 0.29% | 19.336B -0.61% | 19.747B 2.13% | 20.329B 2.95% | 21.187B 4.22% | 22.679B 7.04% | 23.44B 3.36% | 24.246B 3.44% | 24.727B 1.98% | 25.681B 3.86% | 26.652B 3.78% | |
| EBITDA YoY % growth | 3.125B -8.15% | 3.03B -3.03% | 3.008B -0.73% | 3.581B 19.04% | 3.77B 5.28% | 3.989B 5.81% | 4.1B 2.78% | 4.234B 3.27% | 4.771B 12.68% | 4.966B 4.09% | 5.144B 3.58% | 5.327B 3.56% | |
| EBIT YoY % growth | 1.287B -27.66% | 1.278B -0.65% | 1.266B -0.97% | 2.081B 64.39% | 2.235B 7.40% | 2.458B 9.98% | 2.822B 14.81% | 3.019B 6.98% | 3.35B 10.96% | 3.54B 5.67% | 3.679B 3.93% | 3.823B 3.91% | |
| Operating Margin | 6.63% | 6.57% | 6.55% | 10.54% | 10.99% | 11.60% | 12.44% | 12.88% | 13.82% | 14.32% | 14.33% | 14.34% | |
| EPS YoY % growth | 1.54 -10.14% | 1.28 -17.23% | 1.62 26.66% | 1.97 21.73% | 2.06 4.82% | 2.34 13.57% | 2.78 18.65% | 2.90 4.21% | 3.24 11.61% | 3.37 4.09% | 3.62 7.49% | 3.84 6.15% |
All data in EUR
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.46 1.20% | 0.37 -11.62% | 0.39 -13.43% | 0.44 -19.66% | 0.38 -17.75% |
| Revenue Q2Q % growth | 4.876B -4.11% | 5.024B 2.93% | 4.988B 4.09% | 5.124B 4.89% | 5.299B 8.68% |
| EBITDA Q2Q % growth | 1.056B -46.15% | 902.12M 20.02% | 932.15M -19.33% | 984.25M -37.62% | 1.042B -1.33% |
| EBIT Q2Q % growth | 626.94M 186.71% | 511.25M 43.09% | 517.54M 34.11% | 568.13M 26.00% | 668.62M 6.65% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.55 34.15% | 0.48 | 0.07 | 14.16% |
| Q2 2025 Q2Q % growth | 0.45 30.00% | 0.39 | 0.06 | 14.89% |
| Q1 2025 Q2Q % growth | 0.42 2.44% | 0.33 | 0.09 | 27.17% |
| Q4 2024 Q2Q % growth | 0.45 3.41% | 0.39 | 0.06 | 15.03% |
| Q3 2024 Q2Q % growth | 0.41 43.86% | 0.32 | 0.08 | 25.81% |
| Q2 2024 Q2Q % growth | 0.35 17.45% | 0.34 | 0.01 | 2.71% |
| Q1 2024 Q2Q % growth | 0.41 57.69% | 0.30 | 0.11 | 37.27% |
| Q4 2023 Q2Q % growth | 0.44 2.33% | 0.47 | -0.03 | -6.11% |
| Q3 2023 Q2Q % growth | 0.28 -27.85% | 0.26 | 0.02 | 9.44% |
| Q2 2023 Q2Q % growth | 0.30 -22.60% | 0.25 | 0.04 | 16.93% |
| Q1 2023 Q2Q % growth | 0.26 -23.53% | 0.26 | 0.00 | -0.29% |
| Q4 2022 Q2Q % growth | 0.43 -4.44% | 0.39 | 0.03 | 8.43% |
| Q3 2022 Q2Q % growth | 0.39 -15.96% | 0.34 | 0.05 | 15.76% |
| Q2 2022 Q2Q % growth | 0.38 1.32% | 0.41 | -0.03 | -7.29% |
| Q1 2022 Q2Q % growth | 0.34 -20.00% | 0.35 | -0.01 | -2.50% |
| Q4 2021 Q2Q % growth | 0.45 -29.13% | 0.44 | 0.01 | 2.03% |
| Q3 2021 Q2Q % growth | 0.47 -22.31% | 0.46 | 0.01 | 2.46% |
| Q2 2021 Q2Q % growth | 0.38 -36.67% | 0.38 | 0.00 | 0.20% |
| Q1 2021 Q2Q % growth | 0.42 -10.53% | 0.40 | 0.02 | 5.83% |
| Q4 2020 Q2Q % growth | 0.63 | 0.60 | 0.03 | 4.92% |
| Q3 2020 Q2Q % growth | 0.60 | 0.58 | 0.03 | 4.36% |
| Q2 2020 Q2Q % growth | 0.60 | 0.54 | 0.05 | 10.07% |
| Q1 2020 Q2Q % growth | 0.47 | 0.43 | 0.04 | 8.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 4.885B 2.63% | 4.97B | -85M | -1.71% |
| Q2 2025 Q2Q % growth | 4.792B 0.55% | 4.957B | -165M | -3.33% |
| Q1 2025 Q2Q % growth | 4.881B 3.31% | 4.751B | 130M | 2.74% |
| Q4 2024 Q2Q % growth | 5.085B 1.94% | 4.795B | 290M | 6.05% |
| Q3 2024 Q2Q % growth | 4.76B -3.57% | 4.979B | -219M | -4.40% |
| Q2 2024 Q2Q % growth | 4.766B -1.22% | 5.014B | -248M | -4.95% |
| Q1 2024 Q2Q % growth | 4.725B 0.44% | 4.681B | 43.522M | 0.93% |
| Q4 2023 Q2Q % growth | 4.988B -0.18% | 5.002B | -14M | -0.28% |
| Q3 2023 Q2Q % growth | 4.936B -3.14% | 4.952B | -16M | -0.32% |
| Q2 2023 Q2Q % growth | 4.825B 1.44% | 4.824B | 1M | 0.02% |
| Q1 2023 Q2Q % growth | 4.704B 3.42% | 4.767B | -63M | -1.32% |
| Q4 2022 Q2Q % growth | 4.997B 7.53% | 5.054B | -57.198M | -1.13% |
| Q3 2022 Q2Q % growth | 5.096B 14.74% | 5.093B | 3.166M | 0.06% |
| Q2 2022 Q2Q % growth | 4.757B 10.10% | 4.811B | -54.32M | -1.13% |
| Q1 2022 Q2Q % growth | 4.548B 8.03% | 4.516B | 32.369M | 0.72% |
| Q4 2021 Q2Q % growth | 4.647B 5.61% | 4.654B | -6.976M | -0.15% |
| Q3 2021 Q2Q % growth | 4.441B 0.63% | 4.517B | -75.634M | -1.67% |
| Q2 2021 Q2Q % growth | 4.32B -5.20% | 4.363B | -42.83M | -0.98% |
| Q1 2021 Q2Q % growth | 4.21B -6.19% | 4.272B | -61.875M | -1.45% |
| Q4 2020 Q2Q % growth | 4.4B | 4.495B | -94.846M | -2.11% |
| Q3 2020 Q2Q % growth | 4.414B | 4.439B | -25.232M | -0.57% |
| Q2 2020 Q2Q % growth | 4.557B | 4.504B | 53.345M | 1.18% |
| Q1 2020 Q2Q % growth | 4.488B | 4.466B | 21.796M | 0.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -6.06% | 0% | 2.91% |
| Revenue | 0% | 0.58% | 0% | 0.29% |